Table 1 Distribution of the patients according to lines of treatment and DAS28 score
Treatment | Frequency, no. (%) | DAS28 |
|---|---|---|
MTX | 19 (15.83%) | 4.9 ± 2.3 |
MTX + hydroxychloroquine | 16 (13.33%) | 5.15 ± 1.75 |
MTX + sulphasalazine + hydroxychloroquine | 8 (6.66%) | 4.75 ± 2.1 |
Leflunomide | 13 (10.83%) | 6.3 ± 1.9 |
MTX + leflunomide | 12 (10%) | 5.3 ± 2.7 |
Corticosteroids + hydroxychloroquine | 35 (29.19%) | 4.6 ± 2.4 |
Corticosteroids + sulphasalazine | 17 (14.16%) | 5.3 ± 1.8 |